← Browse by Condition
Medical Condition

suicidal ideation

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for suicidal ideation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — suicidal ideation Clinical Trials

How many clinical trials are currently recruiting for suicidal ideation?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for suicidal ideation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for suicidal ideation?
suicidal ideation research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a suicidal ideation clinical trial?
Eligibility criteria for suicidal ideation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
University of Massachusetts, Worcester 2 trials
Centre Hospitalier Esquirol 1 trial
The University of Hong Kong 1 trial
Vastra Gotaland Region 1 trial
Jennifer Hughes 1 trial

Recruiting Clinical Trials

NCT06223867
Recruiting
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
Enrollment
670 pts
Location
United States
Sponsor
University of Massachusetts, W...
View Trial →
NCT07305688
Recruiting
Climate Anxiety in a Young Population at Risk of Suicide
Enrollment
108 pts
Location
France
Sponsor
Centre Hospitalier Esquirol
View Trial →
NCT06804525
Recruiting
LHC-CIDI-5 in Hong Kong
Enrollment
2,500 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →
NCT06831942
Recruiting
Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An Evaluation of a Psychosocial Intervention for Suicidal Adults Aged 65+
Enrollment
132 pts
Location
Sweden
Sponsor
Vastra Gotaland Region
View Trial →
NCT06476886
Recruiting
Intensive Crisis Intervention
Enrollment
213 pts
Location
United States
Sponsor
Jennifer Hughes
View Trial →
NCT07418047
Recruiting
Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults
Enrollment
60 pts
Location
United States
Sponsor
University of Massachusetts, W...
View Trial →
NCT06704958
Recruiting
Augmented Momentary Personal Ecological Risk Evaluation
Enrollment
50 pts
Location
United States
Sponsor
University of Washington
View Trial →
NCT07534358
Recruiting
Intensive Case Management Between VA and Community Care for Suicide Prevention
Enrollment
100 pts
Location
United States
Sponsor
VA Eastern Colorado Health Car...
View Trial →
NCT03646058 Phase 3
Recruiting
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Enrollment
180 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT05183230
Recruiting
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Enrollment
115 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT06315075
Recruiting
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial
Enrollment
140 pts
Location
Norway
Sponsor
Haukeland University Hospital
View Trial →
NCT07043231
Recruiting
Evaluation of Creative Materials Supporting Healthcare Professionals in Discussing Suicidality in Children and Adolescents
Enrollment
40 pts
Location
Belgium
Sponsor
University Ghent
View Trial →
NCT05796531
Recruiting
Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
Enrollment
155 pts
Location
United States
Sponsor
Franciscan Hospital For Childr...
View Trial →
NCT05654207
Recruiting
WeCare: A System of Care for Black Youth
Enrollment
2,200 pts
Location
United States
Sponsor
New York University
View Trial →
NCT07527052
Recruiting
Emerging Technologies and Teen Mental Health
Enrollment
200 pts
Location
United States
Sponsor
Florida International Universi...
View Trial →

Related Conditions

self harm (3) suicide attempt (2) mental health issue (2) suicide (2) suicide attempted (2) suicide and self harm (2) anxiety (1) environmental exposure (1) major depressive episode mde (1) major depressive disorder mdd (1) persistent depressive disorder pdd (1) suicidal plan (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology